Fibrosing interstitial lung diseases: knowns and unknowns
V Cottin, L Wollin, A Fischer… - European …, 2019 - Eur Respiratory Soc
Patients with certain types of fibrosing interstitial lung disease (ILD) are at risk of developing
a progressive phenotype characterised by self-sustaining fibrosis, decline in lung function …
a progressive phenotype characterised by self-sustaining fibrosis, decline in lung function …
[HTML][HTML] Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
JR Brahmer, H Abu-Sbeih, PA Ascierto… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) are the standard of care for the treatment of several
cancers. While these immunotherapies have improved patient outcomes in many clinical …
cancers. While these immunotherapies have improved patient outcomes in many clinical …
Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report
ERF Pérez, WD Travis, DA Lynch, KK Brown… - Chest, 2021 - Elsevier
Background The purpose of this analysis is to provide evidence-based and consensus-
derived guidance for clinicians to improve individual diagnostic decision-making for …
derived guidance for clinicians to improve individual diagnostic decision-making for …
Hypersensitivity pneumonitis: perspectives in diagnosis and management
Awareness of hypersensitivity pneumonitis (HP) as a unique disease entity dates back to the
18th century (1). Since then, numerous inciting agents have been attributed to inducing HP …
18th century (1). Since then, numerous inciting agents have been attributed to inducing HP …
What's in a name? That which we call IPF, by any other name would act the same
AU Wells, KK Brown, KR Flaherty… - European …, 2018 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) remains a truly idiopathic fibrotic disease, with a modest
genetic predilection and candidate triggers but no overall explanation for the development of …
genetic predilection and candidate triggers but no overall explanation for the development of …
Hypersensitivity pneumonitis
U Costabel, Y Miyazaki, A Pardo, D Koschel… - Nature Reviews …, 2020 - nature.com
Hypersensitivity pneumonitis (HP) is a complex syndrome caused by the inhalation of a
variety of antigens in susceptible and sensitized individuals. These antigens are found in the …
variety of antigens in susceptible and sensitized individuals. These antigens are found in the …
Treatment of fibrotic interstitial lung disease: current approaches and future directions
Fibrotic interstitial lung disease (ILD) represents a large group of pulmonary disorders that
are often progressive and associated with high morbidity and early mortality. Important …
are often progressive and associated with high morbidity and early mortality. Important …
Diagnosis, course and management of hypersensitivity pneumonitis
M Hamblin, H Prosch… - European Respiratory …, 2022 - Eur Respiratory Soc
Hypersensitivity pneumonitis (HP) is a complex and heterogeneous interstitial lung disease
(ILD) that occurs when susceptible individuals develop an exaggerated immune response to …
(ILD) that occurs when susceptible individuals develop an exaggerated immune response to …
[HTML][HTML] Progression of fibrosing interstitial lung disease
AW Wong, CJ Ryerson, SA Guler - Respiratory research, 2020 - Springer
Fibrotic interstitial lung diseases (ILDs) are often challenging to diagnose and classify, but
an accurate diagnosis has significant implications for both treatment and prognosis. A …
an accurate diagnosis has significant implications for both treatment and prognosis. A …